axe Neurosciences, Centre de Recherche du CHU de Québec-Université Laval, Pavillon CHUL, 2705 boulevard Laurier, Quebec City, QC G1V 4G2, Canada.
Division of BioMedical Sciences, Faculty of Medicine, Memorial University of Newfoundland, St. John's, NL A1B 3V6, Canada.
Cell Rep. 2021 Mar 9;34(10):108833. doi: 10.1016/j.celrep.2021.108833.
Sex differences in multiple sclerosis (MS) incidence and severity have long been recognized. However, the underlying cellular and molecular mechanisms for why male sex is associated with more aggressive disease remain poorly defined. Using a T cell adoptive transfer model of chronic experimental autoimmune encephalomyelitis (EAE), we find that male Th17 cells induce disease of increased severity relative to female Th17 cells, irrespective of whether transferred to male or female recipients. Throughout the disease course, a greater frequency of male Th17 cells produce IFNγ, a hallmark of pathogenic Th17 responses. Intriguingly, XY chromosomal complement increases the pathogenicity of male Th17 cells. An X-linked immune regulator, Jarid1c, is downregulated in pathogenic male murine Th17 cells, and functional experiments reveal that it represses the severity of Th17-mediated EAE. Furthermore, Jarid1c expression is downregulated in CD4 T cells from MS-affected individuals. Our data indicate that male sex chromosomal complement critically regulates Th17 cell pathogenicity.
性别差异在多发性硬化症(MS)的发病和严重程度上早已被认识到。然而,男性与更严重疾病相关的潜在细胞和分子机制仍未得到明确界定。我们使用慢性实验性自身免疫性脑脊髓炎(EAE)的 T 细胞过继转移模型发现,无论转移到雄性还是雌性受者,雄性 Th17 细胞诱导的疾病严重程度都高于雌性 Th17 细胞。在整个疾病过程中,更多频率的雄性 Th17 细胞产生 IFNγ,这是致病性 Th17 反应的标志。有趣的是,性染色体的补充增加了雄性 Th17 细胞的致病性。一种 X 连锁免疫调节剂,Jarid1c,在致病性雄性鼠 Th17 细胞中下调,功能实验表明它抑制 Th17 介导的 EAE 的严重程度。此外,MS 患者的 CD4 T 细胞中Jarid1c 的表达下调。我们的数据表明,雄性性染色体补充物对 Th17 细胞的致病性具有关键调节作用。